Salesforce Inc vs Nuwellis Inc — how do they compare? Salesforce Inc trades at $195.57 (market cap $161.73B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Salesforce Inc is far larger — about 297955× Nuwellis Inc's market cap, and Salesforce Inc pays a 0.89% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| CRM | NUWE | |
|---|---|---|
Market Cap | $161.73B | $542.80K |
Sector | Technology | Technology |
52-Week High | $266.23 | $220.50 |
52-Week Low | $150.12 | $1.42 |
Enterprise Value | $191.77B | -$1.27M |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $197.51, up 2.47% today, showing strong momentum despite recent sector volatility. The stock demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $3.88 beating expectations of $3.13. Technical indicators show bullish momentum with the price above key support levels, while valuation metrics remain reasonable with P/E of 22.89 and P/S of 4.29. Recent corporate actions include a $0.44 dividend declaration for July 2026 payment.
The outlook remains positive with analyst consensus price target of $230.61 representing 17% upside potential. Strong revenue growth trajectory ($37.9B in 2025 to $42.8B projected for 2026) and expanding profit margins (16.35% to 18.73%) support continued appreciation. Key risks include AI-driven sector volatility and macroeconomic headwinds affecting software spending, but the company's dominant market position and consistent execution provide stability.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Latest headlines on both assets
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →